NCT03405870View on ClinicalTrials.gov

LIPIDS-P Trial Phase I/II Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

April 26, 2023

Study Completion Date

April 26, 2023

Conditions
Sepsis, SevereSeptic Shock
Interventions
DRUG

Smoflipid

Administration of lipid injectable emulsion

Trial Locations (3)

32218

UF Health Jacksonville North campus, Jacksonville

32610

Department of Emergency Medicine, UF Health, Gainesville

UF Health Emergency Medicine, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT03405870 - LIPIDS-P Trial Phase I/II Trial | Biotech Hunter | Biotech Hunter